News

New meta-analysis finds e-cigarette use may increase the risk of heart attack and stroke, even after adjusting for cigarette smoking.

This combined model achieved a high level of accuracy, suggesting that imaging data alongside basic clinical information could be effective for screening.

A UK trial explores immune suppression in early Parkinson’s disease with important lessons for future treatments.

Researchers analysed survey responses from more than 1,000 adults taking part in a large multisite trial of advance care planning.

High HbA1c variability is independently associated with poorer neurocognitive outcomes in children with type 1 diabetes.

Very low-dose multi-nut oral immunotherapy significantly increased tolerance in children with multiple nut allergies, with a favourable safety profile and no epinephrine use.

Phase II ELMWOOD trial shows elafibranor is well tolerated and improves liver biochemistry and pruritus in primary sclerosing cholangitis, supporting further trials.

A clinical trial shows home gamma stimulation may safely improve cognitive outcomes in people with early Alzheimer’s disease.